CB2 Insights

[Not Yet Scheduled]
CB2 Insights’ mission is to transform cannabis into mainstream healthcare through data-driven software and services. We operate the largest network of medical cannabis clinics in the US and deploys proprietary technology within those clinics and other 3rd party operations in order to generate real-world evidence through its predictive analytics engine to further understand the efficacy of cannabis and provide insight to stakeholders throughout both the cannabis and traditional healthcare industry.
Ticker:
CBII / CBIIF
Exchange:
CSE / OTC
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Ontario
Company HQ Country:
Canada
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
SAIL EHR software, Clinical Decision Support tool software
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Executive Officer
CB2 Insights